Xavier Matias-Guiu Guia
Degree: PhD
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Groups
Publications
-
Vrede SW; Kasius J; Bulten J; Teerenstra S; Huvila J; Colas E; Gil-Moreno A; Boll D; Vos MC; van Altena AM; Asberger J; Sweegers S; van Weelden WJ; van der Putten LJM; Amant F; Visser NCM; Snijders MPLM; Küsters-Vandevelde HVN; Kruitwagen R; Matias-Guiu X; Weinberger V; Reijnen C; Pijnenborg JMA
Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer.
JAMA Network Open 5 -. .
-
Palomero J; Panisello C; Lozano-Rabella M; Tirtakasuma R; Díaz-Gómez J; Grases D; Pasamar H; Arregui L; Dorca Duch E; Guerra Fernández E; Vivancos A; de Andrea CE; Melero I; Ponce J; Vidal A; Piulats JM; Matias-Guiu X; Gros A
Biomarkers of tumor-reactive CD4(+) and CD8(+) TILs associate with improved prognosis in endometrial cancer.
Journal for ImmunoTherapy of Cancer 10 -. .
-
Sonzini, G; Granados-Aparici, S; Sanegre, S; Diaz-Lagares, A; Diaz-Martin, J; de Andrea, C; Eritja, N; Bao-Caamano, A; Costa-Fraga, N; García-Ros, D; Salguero-Aranda, C; Davidson, B; López-López, R; Melero, I; Navarro, S; Ramon Y Cajal, Santiago; de Alava, E; Matias-Guiu, X; Noguera, R
Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness.
Frontiers In Cell And Developmental Biology 10 1052098-1052098. .
-
Marín-Jiménez, JA; García-Mulero, S; Matías-Guiu, X; Piulats, JM
Facts and hopes in immunotherapy of endometrial cancer.
CLINICAL CANCER RESEARCH 28 4849-4860. .
-
Matias-Guiu, X; Selinger, CI; Anderson, L; Buza, N; Ellenson, LH; Fadare, O; Ganesan, R; Ip PPC; Palacios, J; Parra-Herran, C; Raspollini, MR; Soslow, RA; Werner HMJ; Lax, SF; McCluggage, WG
Data Set for the Reporting of Endometrial Cancer: Recommendations From the International Collaboration on Cancer Reporting (ICCR).
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 41 90-118. .
-
Barceló, C; Sisó, P; de la Rosa, I; Megino-Luque, C; Navaridas, R; Maiques, O; Urdanibia, I; Eritja, N; Soria, X; Potrony, M; Calbet-Llopart, N; Puig, S; Matías-Guiu, X; Martí, RM; Macià, A
M-CSF as a therapeutic target in BRAF(V600E) melanoma resistant to BRAF inhibitors.
BRITISH JOURNAL OF CANCER 127 1142-1152. .
-
Egan D; Moran B; Wilkinson M; Pinyol M; Guerra E; Gatius S; Matias-Guiu X; Kolch W; le Roux CW; Brennan DJ
CRABP2 - A novel biomarker for high-risk endometrial cancer.
GYNECOLOGIC ONCOLOGY 167 314-322. .
-
Vrede SW; Hulsman AMC; Reijnen C; Van de Vijver K; Colas E; Mancebo G; Moiola CP; Gil-Moreno A; Huvila J; Koskas M; Weinberger V; Minar L; Jandakova E; Santacana M; Matias-Guiu X; Amant F; Snijders MPLM; Küsters-Vandevelde HVN; Bulten J; Pijnenborg JMA
The amount of preoperative endometrial tissue surface in relation to final endometrial cancer classification.
GYNECOLOGIC ONCOLOGY 167 196-204. .
-
Carretero-Barrio I; Lop-Gros J; Iglesias M; Martínez C; Matias-Guiu X; Pérez-Mies B; Palacios J
Impact of the COVID-19 pandemic on pathology training: a survey among Spanish residents.
VIRCHOWS ARCHIV 481 1-5. .
-
Ruiz-Mitjana, A; Navaridas, R; Vidal-Sabanés, M; Perramon-Güell, A; Yeramian, A; Felip, I; Eritja, N; Egea, J; Encinas, M; Matias-Guiu, X; Dolcet, X
Lack of extracellular matrix switches TGF-ß induced apoptosis of endometrial cells to epithelial to mesenchymal transition.
SCIENTIFIC REPORTS 12 14821-14821. .
-
Gatius S; Jove M; Megino-Luque C; Albertí-Valls M; Yeramian A; Bonifaci N; Piñol M; Santacana M; Pradas I; Llobet-Navas D; Pamplona R; Matías-Guiu X; Eritja N
Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer.
Cancers 14 -. .
-
Megino-Luque, C; Sisó, P; Mota-Martorell, N; Navaridas, R; de la Rosa I; Urdanibia, I; Alberti-Valls, M; Santacana, M; Pinyol, M; Bonifaci, N; Macià, A; Llobet-Navas, D; Gatius, S; Matias-Guiu, X; Eritja, N
ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma.
MOLECULAR ONCOLOGY 16 2235-2259. .
Projects
- Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
